Halozyme Therapeutics, Inc. (HALO)
69.29
+2.65
(+3.98%)
USD |
NASDAQ |
Apr 17, 16:00
69.34
+0.05
(+0.07%)
After-Hours: 20:00
Halozyme Therapeutics Market Cap : 8.177B for April 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 564.05B |
| Eli Lilly & Co. | 828.17B |
| Vertex Pharmaceuticals, Inc. | 112.08B |
| Baxter International, Inc. | 9.626B |
| Glaukos Corp. | 7.304B |
Market Cap Related Metrics
| PE Ratio | 27.81 |
| PS Ratio | 6.088 |
| Price to Book Value | 167.52 |
| Price to Free Cash Flow | 13.19 |
| Price | 69.29 |
| Earnings Yield | 3.60% |
| Operating PE Ratio | 10.42 |
| Normalized PE Ratio | 15.09 |